Form 8-K - Current report:
SEC Accession No. 0001564590-20-057511
Filing Date
2020-12-18
Accepted
2020-12-17 18:13:15
Documents
18
Period of Report
2020-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20201217.htm   iXBRL 8-K 56051
2 EX-1.1 scyx-ex11_33.htm EX-1.1 670499
3 EX-4.1 scyx-ex41_46.htm EX-4.1 102200
4 EX-4.2 scyx-ex42_47.htm EX-4.2 105377
5 EX-5.1 scyx-ex51_180.htm EX-5.1 20246
6 GRAPHIC g1xmoabfad3s000001.jpg GRAPHIC 2419
7 GRAPHIC gsmyh1wqj23e000001.jpg GRAPHIC 2401
  Complete submission text file 0001564590-20-057511.txt   1249524

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA scyx-20201217.xsd EX-101.SCH 5776
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20201217_lab.xml EX-101.LAB 19474
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20201217_pre.xml EX-101.PRE 11630
11 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20201217_htm.xml XML 3544
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 201397341
SIC: 2834 Pharmaceutical Preparations